carbetocin
Megjelenés
| Clinical data | |
|---|---|
| Trade names | Duratocin, Pabal, Lonactene, others |
| Other names | (2-O-Methyltyrosine)deamino-1-carbaoxytocin; Deamino-2-O-methyltyrosine-1-carbaoxytocin; 1-Butanoic acid-2-(O-methy-L-tyrosine)-1-carbaoxytocin; 1-butyric acid-2-[3-(4-methoxyphenyl)-L-alanine]oxytocin |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Routes of administration | Intravenous, intramuscular |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | 80% (IM) |
| Elimination half-life | 85–100 minutes[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| Chemical and physical data | |
| Formula | C45H69N11O12S |
| Molar mass | 988.172 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Főnév
carbetocin (tsz. carbetocins)
- carbetocin - Szótár.net (en-hu)
- carbetocin - Sztaki (en-hu)
- carbetocin - Merriam–Webster
- carbetocin - Cambridge
- carbetocin - WordNet
- carbetocin - Яндекс (en-ru)
- carbetocin - Google (en-hu)
- carbetocin - Wikidata
- carbetocin - Wikipédia (angol)